Medical products maker Baxter International said on Monday its CEO José Almeida will retire effective immediately, after ...

Read about the sudden retirement of Baxter International's CEO José Almeida and the company's recovery efforts after a large manufacturing plant was damaged.

Almeida will act as an adviser through Oct. 31. Related: Baxter restarts some production of IV solutions at largest plant The board will consider potential candidates from within and outside the ...

In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded ...

After months of work to clean and restore the facility, Baxter late last year released the first product – 1-liter IV solutions – that was manufactured at the site since the flooding occurred.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the Baxter IV fluids crisis have shown ...

Baxter notified customers on Jan. 22 that allocations for two sodium chloride IV solutions have been increased to 100%. According to Baxter, the products will have a one- to two-week lag time while ...